Patinha, D.; Abreu, C.; Carvalho, C.; Cunha, O.M.; Mota, M.; Afonso, J.; Sousa, T.; Albino-Teixeira, A.; Diniz, C.; Morato, M.
Adenosine A2A and A3 Receptors as Targets for the Treatment of Hypertensive-Diabetic Nephropathy. Biomedicines 2020, 8, 529.
https://doi.org/10.3390/biomedicines8110529
AMA Style
Patinha D, Abreu C, Carvalho C, Cunha OM, Mota M, Afonso J, Sousa T, Albino-Teixeira A, Diniz C, Morato M.
Adenosine A2A and A3 Receptors as Targets for the Treatment of Hypertensive-Diabetic Nephropathy. Biomedicines. 2020; 8(11):529.
https://doi.org/10.3390/biomedicines8110529
Chicago/Turabian Style
Patinha, Daniela, Carla Abreu, Carla Carvalho, Olga Mariana Cunha, Mariana Mota, Joana Afonso, Teresa Sousa, António Albino-Teixeira, Carmen Diniz, and Manuela Morato.
2020. "Adenosine A2A and A3 Receptors as Targets for the Treatment of Hypertensive-Diabetic Nephropathy" Biomedicines 8, no. 11: 529.
https://doi.org/10.3390/biomedicines8110529
APA Style
Patinha, D., Abreu, C., Carvalho, C., Cunha, O. M., Mota, M., Afonso, J., Sousa, T., Albino-Teixeira, A., Diniz, C., & Morato, M.
(2020). Adenosine A2A and A3 Receptors as Targets for the Treatment of Hypertensive-Diabetic Nephropathy. Biomedicines, 8(11), 529.
https://doi.org/10.3390/biomedicines8110529